Notice2021-21666
National Cancer Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 5, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 190 (Tuesday, October 5, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 190 (Tuesday, October 5, 2021)]
[Notices]
[Page 54990]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-21666]
[[Page 54990]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Advisory Board and NCI Board of Scientific Advisors.
The meeting will be held as a virtual meeting and is open to the
public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The meeting will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (<a href="http://videocast.nih.gov/">http://videocast.nih.gov/</a>).
A portion of the National Cancer Advisory Board meeting will be
closed to the public in accordance with the provisions set forth in
section 552b(c)(6), Title 5 U.S.C., as amended. The intramural programs
and projects and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the
intramural programs and projects, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Date: December 7, 2021.
Closed: 12:00 p.m. to 1:00 p.m.
Agenda: Review of intramural program site visit outcomes and the
discussion of confidential personnel issues.
Open: 1:15 p.m. to 4:45 p.m.
Agenda: NCAB Subcommittee Meetings--Subcommittee on Planning and
Budget; Ad Hoc Subcommittee on Experimental Therapeutics; and Ad Hoc
Subcommittee on Population Science, Epidemiology and Disparities.
Place: National Cancer Institute--Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Date: December 8, 2021.
Open: 1:00 p.m. to 5:00 p.m.
Agenda: Joint meeting of the National Cancer Advisory Board and
NCI Board of Scientific Advisors, NCI Director's report and
presentations, NCI Board of Scientific Advisors Concepts Review.
Place: National Cancer Institute--Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Name of Committee: National Cancer Advisory Board and NCI Board
of Scientific Advisors.
Date: December 9, 2021.
Open: 1:00 p.m. to 5:00 p.m.
Agenda: Joint meeting of the National Cancer Advisory Board and
NCI Board of Scientific Advisors, NCI Board of Scientific Advisors
Concepts Review and presentations.
Place: National Cancer Institute--Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Contact Person: Paulette S. Gray, Ph.D., Director, Division of
Extramural Activities, National Cancer Institute--Shady Grove,
National Institutes of Health, 9609 Medical Center Drive, 7th Floor,
Room 7W444, Bethesda, MD 20892, 240-276-6340, <a href="/cdn-cgi/l/email-protection#4e293c2f373e0e232f27226020272660292138"><span class="__cf_email__" data-cfemail="650217041c152508040c094b0b0c0d4b020a13">[email protected]</span></a>.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Information is also available on the Institute's/Center's home
page: NCAB: <a href="https://deainfo.nci.nih.gov/advisory/ncab/ncabmeetings.htm">https://deainfo.nci.nih.gov/advisory/ncab/ncabmeetings.htm</a>,
BSA: <a href="https://deainfo.nci.nih.gov/advisory/bsa/bsameetings.htm">https://deainfo.nci.nih.gov/advisory/bsa/bsameetings.htm</a>, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 30, 2021.
Melanie Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-21666 Filed 10-4-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 5, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.